Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Amgen's revenue for the third quarter ended 30 September 2010 almost remained unchanged at $3.816m, against $3.812m for the same period in 2009.
Subscribe to our email newsletter
Adjusted net income decreased 14% to $1,313m for the third quarter of 2010, compared to $1,518m for the third quarter of 2009.
The decrease in adjusted net income was driven by unusually low research and development costs and favorable tax settlements in the third quarter of 2009.
Operating income was $1.48m, compared to $1.744m for the comparable period in 2009.
For the nine months ended 30 September 2010, Amgen posted a revenue of $11.212m, compared to $10.833m for the year ago period.
For the nine months ended 30 September 2010, operating income was $4.477m, compared to $4.837m for the year ago period.
Amgen is a company that manufactures, discovers, develops and delivers human therapeutics.